Delivery Order SPE2DB20D3303-SPE2DB24FA0YN
Award Date
7/12/24
Potential Completion Date
8/2/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,845,710 units of IBRANCE 100 MG CAPSULE 21S. The $7,518.34 firm fixed-price contract has an ultimate completion date of November 14, 2022 and was awarded on October 21, 2022. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,796.30 contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty cancer medication. The award has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,127.13 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $7,797.84 in firm-fixed-price delivery orders for IBRANCE 75 MG CAPSULE 21S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a July 2024 completion date and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,592.62, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 21, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,488.80, is a delivery order for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty medication. The contract has an ultimate completion date of October 31, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,797.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, with a performance period ending on June 12, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,067.35, is a delivery order for the supply of the drug IBRANCE 75 MG CAPSULE 21S. It is a firm-fixed-price contract with a period of performance through March 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,067.35, is for the supply of IBRANCE 75 MG CAPSULE 21S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...